JMCR Family Office Overview
- Investor Type
-
Family Office
- Status
-
Active
- Professionals
-
5
- Investments
-
31
- Portfolio
-
9
- Exits
-
19
JMCR Family Office General Information
Company Description
Founded in 2013, JMCR Partners is a family office based in Hongkong, China with a regional office based in Boston, Massachusetts and London, United Kingdom. The firm seeks to manage the private assets for the fund's family with three asset management companies JMCR Capital, JMCR Partners, and JMRE, specializing in the fields of private equity and quantitative investment strategies.
Business Details
Website
www.jmcrpartners.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Flat/Room 12015, 12th Floor, LKF Tower
- 33 Wyndham Street
- Hong Kong
- Hong Kong
JMCR Family Office Investments (31)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Eubulus Biotherapeutics | 12-Oct-2021 | Early Stage VC | Biotechnology | Generating Revenue | ||
| Basking Biosciences | 18-Aug-2021 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Riparian Pharmaceuticals | 01-Apr-2021 | Drug Discovery | Out of Business | |||
| Seraxis | 09-Feb-2021 | Biotechnology | Clinical Trials - Phase 1 | |||
| Blue Oak Pharmaceuticals | 05-Feb-2021 | Drug Discovery | Out of Business | |||
| Arthrosi Therapeutics | 22-Oct-2020 | Drug Discovery | Generating Revenue | |||
| Sisu Pharma | 19-Oct-2020 | Drug Discovery | Pre-Clinical Trials | |||
| Anji Pharma | 16-Sep-2020 | Drug Discovery | Out of Business | |||
| Tabomedex | 03-Aug-2020 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Diagon | 18-May-2020 | Later Stage VC | Construction and Engineering | Generating Revenue |
JMCR Family Office Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Riparian Pharmaceuticals | 01-Jun-2026 | Out of Business | |
| Flash Therapeutics | 01-Apr-2026 | ||
| Arthrosi Therapeutics | 09-Feb-2026 | ||
| Anji Pharma | 05-Jun-2025 | ||
| FunPlus | 01-Feb-2025 | ||
| Blue Oak Pharmaceuticals | 12-Dec-2024 | ||
| EPN (Biotechnology) | 01-Jan-2023 | ||
| Mirata Pharmaceuticals | 20-Dec-2021 | ||
| Kickback (Entertainment Software) | 01-Dec-2021 | Out of Business | |
| Amino | 21-Apr-2021 | Merger/Acquisition |
JMCR Family Office Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
JMCR Family Office Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
JMCR Family Office FAQs
-
What is JMCR Family Office?
Founded in 2013, JMCR Partners is a family office based in Hongkong, China with a regional office based in Boston, Massachusetts and London, United Kingdom.
-
When was JMCR Family Office founded?
JMCR Family Office was founded in 2013.
-
Where is JMCR Family Office headquartered?
JMCR Family Office is headquartered in Hong Kong, Hong Kong.
-
How many investments has JMCR Family Office made?
JMCR Family Office has made 31 investments.
-
What has JMCR Family Office invested in?
JMCR Family Office has made numerous investments in companies like Eubulus Biotherapeutics, Basking Biosciences, and Riparian Pharmaceuticals within the Biotechnology and Drug Discovery industries.
-
What has JMCR Family Office invested in recently?
JMCR Family Office's latest investment was on 12-Oct-2021 in Eubulus Biotherapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
